Literature DB >> 28412207

MicroRNA 183 family profiles in pheochromocytomas are related to clinical parameters and SDHB expression.

Suja Pillai1, Chung Y Lo2, Victor Liew3, Minella Lalloz1, Robert A Smith4, Vinod Gopalan1, Alfred King-Yin Lam5.   

Abstract

This study aims to examine the expression profiles of the miR-183 cluster (miR-96/182/183) in pheochromocytoma. Pheochromocytoma tissues were prospectively collected from 50 patients with pheochromocytoma. Expression of miR-183 cluster members and SDHB protein expression were analyzed in these tissues by quantitative real-time polymerase chain reaction and immunohistochemistry, respectively. The expression of miR-183 cluster members in pheochromocytomas was correlated with the clinical and pathological parameters of these patients. The expression levels of miR-183 cluster members were predominantly downregulated or deleted in pheochromocytoma. Low expression or deletion of miR-96 was predominantly noted in younger patients with pheochromocytoma (<50 years, P=.01). Female patients in the study group showed marked deletion of miR-182 (P=.05). Deletion of the cluster was also associated with SDHB protein expression in pheochromocytoma. Moreover, patients with low miR-183 cluster expression had a slightly better survival rate when compared with patients with high expression. To conclude, the findings indicate a role for miR-183 cluster members in the pathogenesis and clinical progression of pheochromocytoma.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenal; MicroRNA-183 cluster; Pheochromocytoma; SDHB; Sporadic

Mesh:

Substances:

Year:  2017        PMID: 28412207     DOI: 10.1016/j.humpath.2017.03.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

Review 1.  What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?

Authors:  Thomas G Papathomas; Diederik P D Suurd; Alfred K Lam; Ronald R de Krijger; Karel Pacak; Arthur S Tischler; Menno R Vriens
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

2.  Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.

Authors:  Bruna Calsina; Luis Jaime Castro-Vega; Rafael Torres-Pérez; Lucía Inglada-Pérez; Maria Currás-Freixes; Juan María Roldán-Romero; Veronika Mancikova; Rocío Letón; Laura Remacha; María Santos; Nelly Burnichon; Charlotte Lussey-Lepoutre; Elena Rapizzi; Osvaldo Graña; Cristina Álvarez-Escolá; Aguirre A de Cubas; Javier Lanillos; Alfonso Cordero-Barreal; Ángel M Martínez-Montes; Alexandre Bellucci; Laurence Amar; Fabio Luiz Fernandes-Rosa; María Calatayud; Javier Aller; Cristina Lamas; Júlia Sastre-Marcos; Letizia Canu; Esther Korpershoek; Henri J Timmers; Jacques Wm Lenders; Felix Beuschlein; Martin Fassnacht-Capeller; Graeme Eisenhofer; Massimo Mannelli; Fátima Al-Shahrour; Judith Favier; Cristina Rodríguez-Antona; Alberto Cascón; Cristina Montero-Conde; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

3.  Editorial: Recent Advances in Pheochromocytoma and Paraganglioma: Molecular Pathogenesis, Clinical Impacts, and Therapeutic Perspective.

Authors:  Farhadul Islam; Ichiro Abe; Suja Pillai; Robert A Smith; Alfred King-Yin Lam
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-23       Impact factor: 5.555

4.  Comprehensive Analysis of Aberrantly Expressed Competitive Endogenous RNA Network and Identification of Prognostic Biomarkers in Pheochromocytoma and Paraganglioma.

Authors:  Zijun Wang; Yijian Li; Yanjun Zhong; Yinhuai Wang; Mou Peng
Journal:  Onco Targets Ther       Date:  2020-11-06       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.